Condition
Reward
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed3
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03681509Not ApplicableCompleted
Pramipexole and Emotional Processing
NCT02179814Not ApplicableSuspended
Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls
NCT02051153Not ApplicableCompleted
Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls
NCT00628706Phase 1CompletedPrimary
Investigating the Acute Effects of THC on Functional Brain Systems
Showing all 4 trials